← All trials
NCT05574010
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 15, 2022
- Primary completion
- Apr 17, 2024
- Completion date
- Apr 2, 2025
- First posted
- Oct 10, 2022
- Last posted
- Dec 5, 2022
- Enrollment
- 138
- Arms / groups
- 7 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Kanyos Bio, Inc.Lead sponsor
- PfizerCollaborator
- Anokion SAStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.